Patents Assigned to Waitaki Biosciences
  • Publication number: 20210322500
    Abstract: A method for producing stable and bioavailable Actinidia deliciosa powder from kiwifruit, including drying kiwifruit pulp to form dried pulp, separately drying kiwifruit skin to form a dried skin, measuring the insoluble fiber content of the dried pulp and the dried skin, and making a blend by adding the dried skin to the dried pulp in an amount to obtain an insoluble fiber content of 10-15% in the blend. The Actinidia deliciosa powder is free of artificial additives, anti-caking agents, or flow agents and has a moisture content of less than about 2.5%.
    Type: Application
    Filed: February 3, 2021
    Publication date: October 21, 2021
    Applicant: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Raumiria Pohatu
  • Patent number: 10744188
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: August 18, 2020
    Assignee: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • Publication number: 20180236039
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Applicant: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • Patent number: 9974841
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: May 22, 2018
    Assignee: WAITAKI BIOSCIENCES
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • Publication number: 20160228517
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Application
    Filed: September 4, 2014
    Publication date: August 11, 2016
    Applicant: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite